Provided by Tiger Trade Technology Pte. Ltd.

CNS Pharmaceuticals, Inc.

3.13
-0.0800-2.49%
Volume:9.52K
Turnover:29.74K
Market Cap:1.94M
PE:-0.14
High:3.32
Open:3.32
Low:3.03
Close:3.21
52wk High:55.20
52wk Low:3.03
Shares:620.30K
Float Shares:539.50K
Volume Ratio:0.54
T/O Rate:1.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-22.7490
EPS(LYR):-466.4490
ROE:-197.11%
ROA:-85.59%
PB:0.20
PE(LYR):-0.01

Loading ...

CNS Pharmaceuticals Inc - Appoints Steve O'loughlin as CFO, Effective March 2 - SEC Filing

THOMSON REUTERS
·
Feb 17

CNS Pharmaceuticals Sets New Executive Compensation Agreements

Reuters
·
Feb 17

CNS Pharmaceuticals Names New CEO and Executive Team

Reuters
·
Feb 17

CNS Pharmaceuticals Inc. Outlines Strategy to Sharpen Focus, Optimize Pipeline, and Align Capital Allocation for Long-Term Value Creation

Reuters
·
Jan 27

CNS Pharmaceuticals says priority ‘is to transform’ how company operates

TIPRANKS
·
Jan 27

CNS Pharmaceuticals Inc trading halted, volatility trading pause

TIPRANKS
·
Jan 15

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:32 AM

Reuters
·
Jan 15

CNS Pharmaceuticals Inc. Files Initial Statement of Beneficial Ownership for CEO and President Rami Levin

Reuters
·
Jan 03

CNS Pharmaceuticals Inc - Appoints Rami Levin as CEO Effective Jan 1, 2026 - SEC Filing

THOMSON REUTERS
·
Dec 17, 2025

CNS Pharmaceuticals Inc - John Climaco Resigns as CEO and Board Member Effective Dec 16, 2025 - SEC Filing

THOMSON REUTERS
·
Dec 17, 2025

CNS Pharmaceuticals Appoints Rami Levin as CEO

Reuters
·
Dec 17, 2025

CNS Pharmaceuticals Held Annual Shareholder Meeting

Reuters
·
Nov 22, 2025

CNS Pharmaceuticals reports Q3 net loss of $3.3 million

Reuters
·
Nov 17, 2025

CNS Pharmaceuticals Unveils New Glioblastoma and Pediatric DMG Clinical Trial Results at SNO 2025

Reuters
·
Nov 10, 2025

CNS Pharmaceuticals Inc announces date for annual stockholder meeting

Reuters
·
Oct 11, 2025

CNS Pharmaceuticals Raised to Buy From Hold by Maxim Group

Dow Jones
·
Sep 12, 2025

CNS Pharmaceuticals Inc : Maxim Group Raises to Buy From Hold

THOMSON REUTERS
·
Sep 12, 2025